Massachusetts Financial Services’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-20,097
Closed -$229K 853
2022
Q4
$229K Buy
20,097
+425
+2% +$6.3K ﹤0.01% 838
2022
Q3
$335K Sell
19,672
-179
-0.9% -$3.84K ﹤0.01% 825
2022
Q2
$426K Buy
+19,851
New +$551K ﹤0.01% 819

Other funds holding CDNA

Massachusetts Financial Services's CDNA Position: Q1 2023 in Review

Massachusetts Financial Services sold out of CareDx (CDNA) in Q1 2023, closing a stake of 20,097 shares — an estimated $229K sold.

Massachusetts Financial Services first reported a position in CDNA in Q2 2022 and held it in 3 quarters. The position peaked at $426K in Q2 2022. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • Massachusetts Financial Services reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • Massachusetts Financial Services sold 20,097 CareDx shares in Q1 2023, an estimated $229K.
  • Massachusetts Financial Services first reported a position in CareDx in Q2 2022 and held it in 3 quarters.
  • Massachusetts Financial Services's CareDx position peaked at $426K in Q2 2022.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on Massachusetts Financial Services's 13F filing for Q1 2023, filed 10 May 2023.